Men with coronary artery disease who used phosphodiesterase-5 (PDE-5) inhibitors for erectile dysfunction had fewer adverse cardiovascular events than those taking the prostaglandin drug alprostadil ...
A 63-y-old man attended the erectile dysfunction clinic. He was initially treated with intracavernosal injection of 20 μg alprostadil (Viridal®). Due to the poor response he used intraurethral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results